Grenada vs Syrian Arab Republic: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Grenada
0.0%
in 2025
Syrian Arab Republic
0.0%
in 2025
Grenada rank
165th
Syrian Arab Republic rank
165th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Grenada
- Syrian Arab Republic
How they compare
Grenada currently reports 0.0% against 0.0% in Syrian Arab Republic, a difference of 0.0%.
Across all 18 years both countries report, Syrian Arab Republic has been ahead every year.
Grenada ranks 165th and Syrian Arab Republic ranks 165th of 192 countries.
Head to head by decade
| Decade | Grenada | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 0.0% | 0.0% | — |
| 2020s | 0.0% | 0.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Grenada or Syrian Arab Republic?
- Grenada, at 0.0% against 0.0% in Syrian Arab Republic as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Grenada and Syrian Arab Republic?
- 0.0%, with Grenada ahead.
- How many years of comparable data are there for Grenada and Syrian Arab Republic?
- 18 years are reported by both, from 2008 to 2025.
- How do Grenada and Syrian Arab Republic rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Grenada ranks 165th and Syrian Arab Republic ranks 165th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.